The Pharmaceutical Formulation Process involves the Constitution of Different Chemical Substances including Active Drugs to produce the Final Medicinal Product. The Dosage Form or Formulation varies according to the Route of Administration.
EFRAC‘s Expert Scientists determine the Quality, Purity, and Stability of Finished products in accordance with Pharmacopoeial Monographs (EP, BP, USP, and JP) and/or to Client specified Requirements. This enables the Products to cater to the Regulatory Requirements of National and International Markets.
Formulation Drug Testing
• LC-MS MS (QQQ) • GC- (FID) • GC- (HEAD SPACE, ECD, MS) • GC-MS MS (QQQ) • HPLC (FLD, PDA, ELSD, RID) • AAS – (Flame, GTA, VGA) • ICP OES • ICP-MS • TOC Analyzer • UV -Visible Spectrophotometer • Brookfield Viscometer • CHNS & O Analyzer • FT-IR • Ion Chromatograph • Karl-Fisher Autotitrator • TGA • DSC • Particle Size Analysis
• Indian Pharmacopoeia
• British Pharmacopoeia
• European Pharmacopoeia
• Japanese Pharmacopoeia
• United States Pharmacopoeia